Quality improvement in gynecologic oncology: Current successes and future promise

被引:16
作者
Kumar, Amanika [1 ]
Nesbitt, Katherine M. [2 ]
Bakkum-Gamez, Jamie N. [1 ]
机构
[1] Mayo Clin, Dept Obstet & Gynecol, Div Gynecol Oncol Surg, Rochester, MN USA
[2] Mayo Clin, Dept Obstet & Gynecol, Qual Off, Rochester, MN USA
关键词
Quality improvement; Six sigma; Lean; DMAIC; Change management; PERIOPERATIVE BLOOD-TRANSFUSION; SURGICAL SITE INFECTION; ADVANCED OVARIAN-CANCER; ENHANCED RECOVERY; CARE; SURVIVAL; IMPACT; GUIDELINES; OUTCOMES; SOCIETY;
D O I
10.1016/j.ygyno.2018.10.046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Quality improvement in healthcare has accelerated over the past two decades, including in gynecologic oncology. Improvements have been made on a practice, institution, system and national scale, and efforts have focused on improving safety, efficiency, and cost of care. Gynecologic oncology practitioners ought to engage in this work to improve patient outcomes, comply with federal regulation, and continue to meet required educational requirements of training programs. In gynecologic oncology there are already many examples of successful quality improvement initiatives that have resulted in improved patient care, including the implementation of enhanced recovery after surgery programs, reduction in blood transfusion, and increases in guideline adherent cancer care. Quality improvement methodology is born out of industrial engineering and includes Six Sigma and Lean; both are frameworks for implementing quality improvement as a process and can be adopted in healthcare settings to achieve the desired outcomes. Six Sigma is a system that aims to have a 99.9997% defect free process, and uses the DMAIC (Define-Measure-Analyze-Improve-Control) framework to guide stakeholders in their work. Lean is a concept aimed at reducing waste in process. Regardless of methodology used, the most important aspect of successful quality improvement is the use of change-management theory to achieve stakeholder buy-in and institutional participation. The physician champion is a key element to this. Finally, once a project has been completed, successfully or not, it is important to disseminate the experience. This will allow for adoption and replication in other institutions. It also can serve as a mechanism for academic recognition and advancement. Quality improvement is an important and growing field in medicine, and has an important role in the future of gynecologic oncology. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:486 / 491
页数:6
相关论文
共 37 条
  • [1] Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma
    Abu-Ghanem, Yasmin
    Zilberman, Dorit E.
    Dotan, Zohar
    Kaver, Issac
    Ramon, Jacob
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (01) : 12.e15 - 12.e20
  • [2] ACGME, 2015, OBST GYN MIL PROJ
  • [3] ACGME, 2015, GYN ONC MIL PROJ
  • [4] Intensive postoperative glucose control reduces the surgical site infection rates in gynecologic oncology patients
    Al-Niaimi, Ahmed N.
    Ahmed, Mostafa
    Burish, Nikki
    Chackmakchy, Saygin A.
    Seo, Songwon
    Rose, Stephen
    Hartenbach, Ellen
    Kushner, David M.
    Safdar, Nasia
    Rice, Laurel
    Connor, Joseph
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 136 (01) : 71 - 76
  • [5] Quality Improvement in the Surgical Approach to Advanced Ovarian Cancer: The Mayo Clinic Experience
    Aletti, Giovanni D.
    Dowdy, Sean C.
    Gostout, Bobbie S.
    Jones, Monica B.
    Stanhope, Robert C.
    Wilson, Timothy O.
    Podratz, Karl C.
    Cliby, William A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 208 (04) : 614 - 620
  • [6] Do packed red blood cell transfusions really worsen oncologic outcomes in colon cancer?
    Amri, Ramzi
    Dinaux, Anne M.
    Leijssen, Lieve G. J.
    Kunitake, Hiroko
    Bordeianou, Liliana G.
    Berger, David L.
    [J]. SURGERY, 2017, 162 (03) : 586 - 591
  • [7] [Anonymous], 2001, CROSSING QUALITY CHA
  • [8] [Anonymous], 1999, ERR IS HUMAN
  • [9] Brassard M., 2002, 6 SIGMA MEMORY JOGGE, V1st
  • [10] High-volume ovarian cancer care: Survival impact and disparities in access for advanced-stage disease
    Bristow, Robert E.
    Chang, Jenny
    Ziogas, Argyrios
    Randall, Leslie M.
    Anton-Culver, Hoda
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 132 (02) : 403 - 410